StockNews.AI
XRAY
StockNews.AI
209 days

XRAY DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in DENTSPLY SIRONA Inc. (XRAY) Securities Fraud Class Action Lawsuit

1. Securities class action lawsuits filed against DENTSPLY for misleading statements. 2. Allegations include targeting low-income patients and selling to contraindicated individuals. 3. Reported serious patient injuries linked to Byte aligners increased significantly. 4. DENTSPLY failed to notify the FDA of Byte-related injuries in time. 5. Investors can seek to be lead plaintiffs by January 27, 2025.

6m saved
Insight
Article

FAQ

Why Bearish?

It indicates legal troubles due to alleged negligence and fraud. Similar past cases have led to stock declines.

How important is it?

The legal issues reported have a direct impact on investor confidence and stock price. Such lawsuits often correlate with market reactions.

Why Short Term?

Immediate legal implications could affect investor sentiment quickly. Previous litigation often results in stock volatility.

Related Companies

XRAY
RADNOR, Pa., Jan. 22, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that securities class action lawsuits have been filed against DENTSPLY SIRONA Inc. ("DENTSPLY") (NASDAQ: XRAY) on behalf of those who purchased or otherwise acquired DENTSPLY common stock between May 6, 2021, and November 6, 2024, inclusive (the "Class Period"). The lead plaintiff deadline is January 27, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:If you suffered DENTSPLY losses, you may CLICK HERE or copy and paste this link into your browser: https://www.ktmc.com/new-cases/dentsply-sirona-inc?utm_source=PR&utm_medium=link&utm_campaign=xray&mktm=r You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected]. DEFENDANTS' ALLEGED MISCONDUCT:The complaints allege that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) DENTSPLY targeted low-income people who did not have access to good oral hygiene education, a dentist, or dental insurance, which often meant patients signing up for Byte, a direct-to-consumer aligner solution, had underlying dental issues that would have made them ineligible for treatment; (2) the push for Byte growth and sales commissions caused sales employees to sell to contraindicated patients; (3) as a result of the above, the Byte patient onboarding workflow did not provide adequate assurance that contraindicated patients did not enter treatment; (4) before and during the Class Period, reports of Byte patient injuries were pouring in; (5) DENTSPLY knew that its Byte aligners were causing severe patient injuries for years but did little to investigate those injuries or notify the FDA; (6) DENTSPLY had no systems in place to notify the FDA of these injuries, which Dentsply is required to do within 30 days of learning of a problem; (7) the FDA had received a sharp uptick in reports of serious injuries from Byte patients; (8) as a result of the above, DENTSPLY materially overstated the goodwill value of Byte; and (9) as a result of the above, Defendants' positive statements about DENTSPLY's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. THE LEAD PLAINTIFF PROCESS:DENTSPLY investors may, no later than January 27, 2025, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.  The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. Kessler Topaz Meltzer & Check, LLP encourages DENTSPLY investors who have suffered significant losses to contact the firm directly to acquire more information. CLICK HERE TO SIGN UP FOR THE CASE OR GO TO: https://www.ktmc.com/new-cases/dentsply-sirona-inc?utm_source=PR&utm_medium=link&utm_campaign=xray&mktm=r ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP: Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.  The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com. CONTACT:Kessler Topaz Meltzer & Check, LLPJonathan Naji, Esq.(484) 270-1453280 King of Prussia RoadRadnor, PA 19087[email protected] May be considered attorney advertising in certain jurisdictions.  Past results do not guarantee future outcomes. SOURCE Kessler Topaz Meltzer & Check, LLP

Related News